Developmental pluripotency-associated 4 (DPPA4) was found to be a poor prognostic factor in NSCLC patients due to the enhancement of glycolytic metabolism via increased activity of LDHB, HK2, and GLUT4 (Li L. et al., 2019). Here, HK2 is linked to non-small cell lung carcinoma.